Back

Does the efficacy of DOACs in atrial fibrillation differ by heart failure phenotype? a real-world analysis of 315,000 patients

31 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation in heart failure: predictors and outcomes Heart Failure in Atrial Fibrillation ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jacob Hicks

Emory Healthcare, Atlanta (United States of America)

6 More presentations in this session

Presentation thumbnail
Early vs delayed ablation for atrial fibrillation in heart failure with reduced ejection fraction
Doctor A. Maan (Toledo, US)
Abstract Slides Video
Presentation thumbnail
Left atrial contraction strain as a predictor of device-detected atrial fibrillation in patients with heart failure with reduced ejection fraction.
Doctor M. Dabrowska (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Epicardial adipose tissue predicts early-stage atrial fibrillation in heart failure with preserved ejection fraction
Mr S. Deng (Taipei, TW)
Abstract Slides Video
Presentation thumbnail
Effect of sex on atrial fibrillation ablation in heart failure: a post hoc analysis of the RAFT-AF Trial
Doctor R. Parkash (Halifax, CA)
Abstract Slides Video
Presentation thumbnail
Adverse impact of extensive left atrial ablation on long-term heart failure outcomes in paroxysmal atrial fibrillation
Doctor M. Ochi (Amagasaki, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation in heart failure: predictors and outcomes

The Event

Event poster

ESC Congress 2026

31 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Vascular disease and renal impairment mediate the higher thromboembolic risk in atrial fibrillation patients with heart failure with reduced ejection fraction
29 August 2026
thumbnail
Congress Presentation
From prescription to outcome: real-world utilization of direct oral anticoagulants in atrial fibrillation across Europe
14 April 2026
thumbnail
Congress Presentation
There is a role for anticoagulation in patients with HFrEF in sinus rhythm: con
26 August 2023
thumbnail
Congress Presentation
Glucagon-like peptide-1 receptor agonists reduce atrial fibrillation among patients with heart failure with preserved ejection fraction - A meta-analysis of randomised-controlled trials
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources